FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention refers to pharmacy. Disclosed is the use of lithium folate of formula Li2C19H17N7O6⋅nH2O as a cytoprotective agent. Invention can be used in medicine and biology.
EFFECT: technical result: pronounced cytoprotective action on mononuclear cells in toxic effect of hydroperoxide.
1 cl, 1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT POSSESSING APOPTOSIS-INHIBITING ACTIVITY | 2018 |
|
RU2677877C1 |
AGENT OF APOPTOSIS-INDUCTIVE ACTIVITY | 2017 |
|
RU2654711C1 |
RADIOSENSITIZER | 2019 |
|
RU2720455C1 |
APOPTOSIN AND ANTIOXIDANT COMPOSITION | 2017 |
|
RU2682644C2 |
METHOD FOR NK-CELLS CYTOTOXIC ACTIVITY DETERMINATION | 2016 |
|
RU2632109C1 |
RADIOPROTECTIVE AGENT | 2020 |
|
RU2737898C1 |
METHOD FOR DETERMINING MINIMUM EFFECTIVE CONCENTRATION OF ANTITUMOUR DRUG WHICH INHIBITS CYTOPROTECTIVE AUTOPHAGY IN VITRO | 2018 |
|
RU2693829C1 |
METHOD OF QUANTITATIVE ESTIMATION OF APOPTOSIS MODIFIED BY ORGANIC LOW-MOLECULAR COMPOUNDS | 2011 |
|
RU2471190C1 |
PHARMACEUTICAL COMPOSITION EXHIBITING CYTOTOXIC EFFECT ON HUMAN BLADDER CANCER CELLS | 2018 |
|
RU2693378C1 |
METHOD OF ASSESSING THE RISK OF NON-PREGNANCY IN WOMEN WITH USUAL MISCARRIAGE | 2017 |
|
RU2657433C1 |
Authors
Dates
2020-03-23—Published
2019-03-01—Filed